Cetuximab (C225) is a monoclonal antibody that is an inhibitor of human epidermal growth factor receptor (EGFR) (Kd=0.201 nM). Cetuximab has antitumor activity, inhibiting tumor cell proliferation and inducing apoptosis.
Purity:
95.70%
CAS Number:
[205923-56-4]
Target:
EGFR
T9905
* VAT and and shipping costs not included. Errors and price changes excepted